Forty-three infants, treated with aminoglycosides during the neonatal period, were tested repeatedly over a period of two to five years for neurovestibular responses. Results of testing were compared with those obtained from a group of 276 healthy newborns followed simultaneously. No abnormalities were found in the untreated group. Among the treated infants, three had a sensorineural hearing loss and eight had laboratory evidence of vestibular dysfunction and delay of head and postural control.
Get full access to this article
View all access options for this article.
References
1.
Panel Discussion: Kanamycin in pediatric practice with special reference to observations on ototoxicity. Ann NY Acad Sci132: 1037–1044, 1966.
2.
de Klejn, in discussion, WalshFMR: Posture and reflexes. Brain47: 383, 1924.
3.
RapinJ: Hypoactive labyrinths and motor development. Clin Pediatr13: 922–936, 1974.
4.
EviatarLEviatarA: Neurovestibular examination of infants and children. Adv Otorhinolaryngol23: 169, 1978.
5.
EviatarLEviatarA: The normal nystagmic response of infants to caloric and perrotatory stimulation. Laryngoscope89: 1036–1044, 1979.
6.
YowMDTenggTBangsT: The ototoxic effects of kanamycin sulfate in infants and children. J Pediatr60: 230, 1962.
7.
ElfvingTPettayORairoM: A follow-up study on the cochlear, vestibular and renal function in children treated with gentamicin in the newborn period. Chemotherapy18: 141, 1973.
8.
Finitzo-HieberTMcCrackenGHRoeserRJ: Ototoxicity in neonates treated with gentamicin and kanamycin: Results of a 4-year controlled follow-up study. Pediatrics63: 443–449, 1979.
